News

August 18, 2020
New paper published in Lancet Rheumatology on immune cell signatures in JSLE patients, discovered by machine learning techniques AND extensive  laboratory work AND clinical knowledge. Really happy to have the…
by pierre in News  0
May 7, 2020
SciCross partners with scientists from Uppsala University, KTH and SciLifeLab in developing Covid-19 treatments in immune suppressed individuals. The project is called “An adaptable therapeutic technology platform to treat SARS-CoV…
by pierre in News  0
December 20, 2019
Great news before Christmas. SciCross is part of a project receiving funding from the Swedish Knowledge Foundation. The project title is “Biomedical AI-driven data analytics” (BIO-AID) and will start in…
by pierre in Uncategorized  0
July 4, 2019
In a recent paper written with colleagues from the ABIRISK consortium we present a study of the genetic risk associated with inhibitor development in patients with severe hemophilia A. #ABIRISK…
by pierre in News  0
May 31, 2019
A recent paper originating from ABIRISK research has been made available online. The paper presents an analysis of retrospective data in European cohort of RA patients treated with adalimumab or…
by pierre in Uncategorized  0
November 16, 2018
A better understanding of the blood-brain barrier (BBB) is key for developing treatments for disease like MS and Alzheimer's. In a collaboration with AstraZeneca, KTH, Karolinska Institute and University of Skövde  we…
by pierre in News, Uncategorized  0
October 19, 2018
Paper describing the effect of Methotrexate and BAFF levels during TNF inhibitor treatment in RA patients. Work done within the ABIRISK project with SciCross contributing in the managements of clinical…
by pierre in Uncategorized  0
August 16, 2018
In a recent paper, published in Journal of Clinical Investigation Insight, we describe a number of factors that influence the risk of immunogenicity responses (anti drug antibodies, ADA) in Multiple…
by pierre in News  0